Mayer W J, McWhorter W P
Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, MD 20892.
Am J Public Health. 1989 Jun;79(6):772-5. doi: 10.2105/ajph.79.6.772.
Analysis of 20,764 White and 882 Black bladder cancer patients diagnosed during 1978-85 indicates that Black patients were more likely than White patients to go untreated following diagnosis after adjustment for age- and stage-at-diagnosis, sex, and tumor histology (OR = 1.80, 95% CI = 1.33, 2.43). Treatment status was found to be a significant predictor of five-year survival after adjustment (treated/untreated odds ratio = 3.16, 95% CI = 2.08, 4.79). Results suggest that differences in initial therapy may contribute to the survival differential between Black and White bladder cancer patients.
对1978年至1985年间确诊的20764名白人膀胱癌患者和882名黑人膀胱癌患者的分析表明，在对诊断时的年龄、分期、性别和肿瘤组织学进行调整后，黑人患者在诊断后未接受治疗的可能性高于白人患者（比值比=1.80，95%置信区间=1.33，2.43）。研究发现，在进行调整后，治疗状态是五年生存率的一个重要预测因素（接受治疗/未接受治疗的比值比=3.16，95%置信区间=2.08，4.79）。结果表明，初始治疗的差异可能导致黑人和白人膀胱癌患者的生存差异。
